Search Results

DCGI Highlights India's Contributions to Global Healthcare; Pharmaceutical Industry's Future Directions

Batch-specific recall of painkillers, antifungals, and diabetes drugs; spurious products traced to unauthorized manufacturers

New code may have some implications for the pharmaceutical companies but would benefit consumers

The Drug Controller General of India has asked state and Union Territory regulators to withdraw AstraZeneca's cancer drug Olaparib

The distribution of generic, cheap drugs to children with spinal muscular atrophy raised concerns in parents at SAT government hospital

Experimental triple-hormone therapy achieved up to 24.2% weight loss in Phase 2 trials, but it remains under investigation and is not yet FDA approved.